Continuous Dual Glucose-Ketone Monitoring
Diabetes Technology & Therapeutics · 01.11.2025 · 27 (4_suppl)
DOI: 10.1089/dia.2025.0300 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diabetes Technology & Therapeutics, online erschienen am 09.07.2025. Verfasst von Celeste Durnwald und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Diabetic Ketoacidosis, Ketones, Blood Glucose, Pregnancy in Diabetics. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
Diabetic ketoacidosis (DKA) occurring during pregnancy is an obstetric emergency that can result in significant adverse outcomes for both the pregnant person and the fetus. While DKA generally presents with glucose levels >250 mg/dL, up to 30% of DKA cases involve euglycemic DKA (euDKA) wherein glucose levels
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Barbara Davis Center for Diabetes, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, USA.
ORCID-Profile: Celeste Durnwald, Sarit Polsky
Zitieren
APA
Durnwald, C., & Polsky, S. (2025). Continuous Dual Glucose-Ketone Monitoring. Diabetes Technology & Therapeutics, 27(4_suppl). https://doi.org/10.1089/dia.2025.0300
Vancouver
Durnwald C, Polsky S. Continuous Dual Glucose-Ketone Monitoring. Diabetes Technology & Therapeutics. 2025;27(4_suppl). doi:10.1089/dia.2025.0300
BibTeX
@article{Durnwald2025,
author = {Durnwald, Celeste and Polsky, Sarit},
title = {Continuous Dual Glucose-Ketone Monitoring},
journal = {Diabetes Technology & Therapeutics},
year = {2025},
volume = {27},
number = {4_suppl},
doi = {10.1089/dia.2025.0300}
}
EUVIMED